Voyager Therapeutics, Inc. Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31)
Voyager Therapeutics, Inc. (VYGR) reported Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) of -$20.05 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-03.
Discontinued › Notes › Equity
us-gaap:CumulativeEffectOnRetainedEarningsNetOfTax1 · last filed 2020-03-03
- Voyager Therapeutics, Inc. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2018-03-31 was -$20.05M.
- Voyager Therapeutics, Inc. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for fiscal 2018 was -$20.05M.
| Period end | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 3 month | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 12 month |
|---|---|---|
| 2018-12-31 | -$20.05M 10-K · filed 2020-03-03 | |
| 2018-03-31 | -$20.05M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |